NEUROTOXICITY ASSOCIATED WITH DEFEROXAMINE THERAPY

被引：24
|
作者：
FREEDMAN, MH
BOYDEN, M
TAYLOR, M
SKARF, B
机构：
[1] UNIV TORONTO,HOSP SICK CHILDREN,DIV AUDIOL,TORONTO M5G 1X8,ONTARIO,CANADA
[2] UNIV TORONTO,HOSP SICK CHILDREN,DIV NEUROL,TORONTO M5G 1X8,ONTARIO,CANADA
[3] UNIV TORONTO,HOSP SICK CHILDREN,DEPT PEDIAT,TORONTO M5G 1X8,ONTARIO,CANADA
[4] UNIV TORONTO,HOSP SICK CHILDREN,DEPT OTOLARYNGOL,TORONTO M5G 1X8,ONTARIO,CANADA
来源：
TOXICOLOGY | 1988年 / 49卷 / 2-3期
关键词：
D O I：
10.1016/0300-483X(88)90010-8
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：283 / 290
页数：8
相关论文
共 50 条
  • [41] IRON CHELATION THERAPY WITH DEFEROXAMINE IN COOLEY ANEMIA
    COHEN, A
    SCHWARTZ, E
    JOURNAL OF PEDIATRICS, 1978, 92 (04): : 643 - 647
  • [42] Intranasal Deferoxamine: the future of neurological disease therapy?
    Kosyakovsky, Jacob
    Fine, Jared M.
    Frey, William H.
    Hanson, Leah R.
    SOUTHERN MEDICAL JOURNAL, 2021, 114 (08)
  • [43] COMPARISON OF DEFEROXAMINE PHARMACOKINETICS BETWEEN ASYMPTOMATIC THALASSEMIC CHILDREN AND THOSE EXHIBITING SEVERE NEUROTOXICITY
    BENTUR, Y
    KOREN, G
    TESORO, A
    CARLEY, H
    OLIVIERI, N
    FREEDMAN, MH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 47 (04) : 478 - 482
  • [44] EFFECTIVENESS AND COMPLICATIONS OF INTENSIVE DEFEROXAMINE THERAPY FOR HEMOSIDEROSIS
    GALACTEROS, F
    GOLDSCHMIDT, E
    BOUCHARD, P
    MACHOVER, D
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1987, 29 (05): : 343 - 343
  • [45] Adherence to deferoxamine therapy: Heeding hippocrates and osler
    Watkins, F
    Fidler, C
    Boultwood, J
    Wainscoat, JS
    AMERICAN JOURNAL OF HEMATOLOGY, 2004, 76 (04) : 417 - 417
  • [46] Deferoxamine therapy for intracerebral hemorrhage: A systematic review
    Zeng, Liling
    Tan, Li
    Li, Haijun
    Zhang, Qixin
    Li, Yongxian
    Guo, Jianwen
    PLOS ONE, 2018, 13 (03):
  • [47] THALASSEMIA MAJOR - CHELATION-THERAPY WITH DEFEROXAMINE
    DEMIANI, MSA
    DEHERRLEIN, MES
    PENALVER, JA
    MEDICINA-BUENOS AIRES, 1985, 45 (03) : 231 - 234
  • [48] DEFEROXAMINE THERAPY IN HIGH-FERRITIN DIABETES
    CUTLER, P
    DIABETES, 1989, 38 (10) : 1207 - 1210
  • [49] WHY DEFEROXAMINE THERAPY PREDISPOSES TO YERSINIA SEPSIS
    WARREN, JJ
    ACTA HAEMATOLOGICA, 1987, 77 (03) : 191 - 191
  • [50] NEUROTOXICITY OF ANTIBACTERIAL THERAPY
    THOMAS, RJ
    SOUTHERN MEDICAL JOURNAL, 1994, 87 (09) : 869 - 874
12345